‘There are still open questions [surrounding nanotechnology], but that applies to many emerging risks from new technologies‘ reads one of the main conclusions of a report about ‘The Information Needs of the (Re-)Insurance Industry’ concerning the risks posed by nanotechnologies; the quote was one of the concluding remarks given by Read more…
… the promise of SynBio for the benefit of global society and industry will only be met if significant advances are achieved on the standardisation front. [The long journey towards standards for engineering biosystems, EMBO Rep (2020) e50521, https://doi.org/10.15252/embr.202050521] A joint group of of experts in synthetic biology (SynBio) and Read more…
During the 8th Plant Genomics and Gene Editing Congress: Europe, held on the 4th and 5th March 2020 in Rotterdam, a panel of experts explored end discussed ‘The Regulatory Landscape’ of Genome Editing: Chair: Huw Jones, Professor of Translational Genomics for Plant Breeding, Institute of Biological, Environmental & Rural Sciences (IBERS), Read more…
The organisers of the ‘OECD Conference on Genome Editing: Applications in Agriculture – Implications for Health, Environment and Regulation’ published ‘An overview of regulatory approaches to genome editing in agriculture’. The article summarises the OECD Conference session on ‘Regulatory Aspects of Genome Editing’, during which government representatives from six different Read more…
The long-awaited ‘Meeting Report of the OECD Conference on “Genome Editing: Applications in Agriculture—Implications for Health, Environment and Regulation”’ of the seminal OECD Conference, held on the 28. – 29. June 2018 has now been published (Transgenic Research, August 2019, Volume 28, Issue 3–4, pp 419–463; DOI: https://doi.org/10.1007/s11248-019-00154-1). The Conference brought together policy makers, Read more…
This year’s CRISPRcon aimed to tackle the big questions of Science, Society and the Future of Gene Editing in Wageningen, The Netherlands, on the 20. and 21. June 2019. What influences how societies view, value and engage with technological innovation?, What does history teach us about the emergence of new Read more…
‘Policy Considerations Regarding Genome Editing’ (DOI: https://doi.org/10.1016/j.tibtech.2019.05.005) have now been published in the latest ‘online now’-edition of Trends in Biotechnology. Summarising the policy discussions during the seminal OECD Conference, held on the 28. – 29. June 2018, this scientific article highlights the manifold arguments for and against more stringent regulations of genome Read more…
AcumenIST Steffi Friedrichs was one of eight international experts from the fields of biomedicine, law, and ethics at this year’s Marsilius Kolleg (Heidelberg University) Winter School Symposium on “Global Governance of Human Germline Genome Editing”.
![Development in biotechnology patent applications, 1990-2012 (number of IP5 patent families by inventor’s country and priority date; see also: NOTE and SOURCE below) [Source (adapted): Steffi Friedrichs, OECD STI Working Papers, 2018/06]](https://acumenist.com/wp-content/uploads/2018/03/20180327_Fig2-1-Development-in-biotechnology-patent-applications-1990-to-2012-360x240.jpg)
On the 8. October 2018, Dr Steffi Friedrichs, Founder & Director of AcumenIST, was the invited NanoEarth Industry Speaker at Virginia Tech.
In a presentation entitled “The ‘Rise and Fall’ of Technologies (on the Example of Biotech and Nanotech)”, Steffi highlighted the difference between the two technologies and outline the potential pitfalls (for both the public and the private sector) in reducing the expected trajectory of any technology’s development to a mere copy of a previous experience.
AcumenIST Steffi Friedrichs delivered a Policy Brief during the closing session of the international gene editing conference “CRISPRing – A New Beginning for the Genetic Improvement of Plants and Microbes” , which was held on the 3.-5. September 2018 in Budapest, Hungary.
